Scholarlink

Purpose <p>We sought to evaluate the efficacy of intravenous dexamethasone in reducing rebound pain post-orthopedic wrist and hand surgery, administered prior to supraclavicular brachial plexus blockade.</p> Methods <p>We conducted a randomized placebo-controlled trial on 56 patients scheduled for elective wrist and hand surgery under supraclavicular brachial plexus blockade. We randomized participants into either a control group, receiving 0.9% of intravenous saline, or a dexamethasone group, receiving 0.11&#xa0;mg·kg<sup>−1</sup> of intravenous dexamethasone. The primary outcome was the difference in pain scores before <i>vs</i> after block resolution. Secondary outcomes included the incidence of rebound pain, pain scores, cumulative opioid consumption, patient satisfaction with postoperative analgesia, and block-related complications in the first 24&#xa0;hr postoperatively.</p> Results <p>The mean (standard deviation [SD]) pain score difference was significantly larger in the control group (7.3 [1.9]) compared with the dexamethasone group (4.7 [2.1]), with a mean difference between groups of 2.6 (95% confidence interval, 1.5 to 3.7; <i>P</i> &lt; 0.001). The incidence of rebound pain was also significantly higher in the control group (79% <i>vs</i> 32%; <i>P</i> &lt; 0.001). The cumulative opioid consumption in 24&#xa0;hr was greater in the control group than in the dexamethasone group (median [interquartile range (IQR)], 72 [54–97] mg <i>vs</i> 25 [14–60] mg; <i>P</i> &lt; 0.001). We found no significant differences in postoperative complications.</p> Conclusions <p>Preoperative administration of 0.11&#xa0;mg·kg<sup>−1</sup> intravenous dexamethasone significantly reduced rebound pain within 24&#xa0;hr after wrist and hand surgery under supraclavicular brachial plexus blockade. The results of our trial support the use of intravenous dexamethasone as an effective method for managing postoperative pain for wrist and hand surgery under supraclavicular brachial plexus blockade.</p> <p><b>Study registration:</b> www.CRIS.nih.go.kr (<a href="https://clinicaltrials.gov/ct2/show/KCT0007208">KCT0007208</a>); first submitted 5 April 2022.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The effect of intravenous dexamethasone on rebound pain after wrist and hand surgery under supraclavicular brachial plexus blockade: a randomized placebo-controlled trial

  • 期刊论文

  • 发表日期：

    2025年6月20日

查看全文
  • RyungA Kang,
  • Yu Jeong Bang,
  • Jae Woo Shim,
  • Soo Joo Choi,
  • So Myung Kong,
  • Tae Soo Hahm,
  • Jungchan Park,
  • Woo Seog Sim,
  • Justin Sangwook Ko

摘要

Purpose

We sought to evaluate the efficacy of intravenous dexamethasone in reducing rebound pain post-orthopedic wrist and hand surgery, administered prior to supraclavicular brachial plexus blockade.

Methods

We conducted a randomized placebo-controlled trial on 56 patients scheduled for elective wrist and hand surgery under supraclavicular brachial plexus blockade. We randomized participants into either a control group, receiving 0.9% of intravenous saline, or a dexamethasone group, receiving 0.11 mg·kg−1 of intravenous dexamethasone. The primary outcome was the difference in pain scores before vs after block resolution. Secondary outcomes included the incidence of rebound pain, pain scores, cumulative opioid consumption, patient satisfaction with postoperative analgesia, and block-related complications in the first 24 hr postoperatively.

Results

The mean (standard deviation [SD]) pain score difference was significantly larger in the control group (7.3 [1.9]) compared with the dexamethasone group (4.7 [2.1]), with a mean difference between groups of 2.6 (95% confidence interval, 1.5 to 3.7; P < 0.001). The incidence of rebound pain was also significantly higher in the control group (79% vs 32%; P < 0.001). The cumulative opioid consumption in 24 hr was greater in the control group than in the dexamethasone group (median [interquartile range (IQR)], 72 [54–97] mg vs 25 [14–60] mg; P < 0.001). We found no significant differences in postoperative complications.

Conclusions

Preoperative administration of 0.11 mg·kg−1 intravenous dexamethasone significantly reduced rebound pain within 24 hr after wrist and hand surgery under supraclavicular brachial plexus blockade. The results of our trial support the use of intravenous dexamethasone as an effective method for managing postoperative pain for wrist and hand surgery under supraclavicular brachial plexus blockade.

Study registration: www.CRIS.nih.go.kr (KCT0007208); first submitted 5 April 2022.